Semnur Pharmaceuticals, Inc.(SMNR)
Pharmaceuticals
CNS / Psychiatry Pharma
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-09-25 | Scilex Holding Co 10% Owner | Sale | -12,500,000 | -6.42%182,304,849 | $16.00 | $200,000,000 | View SEC filing | |
| 2024-09-16 | Denali Capital Global Investments LLC 10% Owner | Sale | -500,000 | -20.47%1,942,500 | N/A | N/A | View SEC filing | |
| 2024-09-16 | Xu Jiandong 10% Owner | Sale | -500,000 | -20.47%1,942,500 | N/A | N/A | View SEC filing | |
| 2022-04-13 | Denali Capital Global Investments LLC 10% Owner | Purchase | +510,000 | +100.00%510,000 | $10.00 | $5,100,000 | View SEC filing | |
| 2022-04-13 | Xu Jiandong 10% Owner | Purchase | +510,000 | +100.00%510,000 | $10.00 | $5,100,000 | View SEC filing |
1-5 of 5